Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Pharmacotherapy
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
Pharmacotherapy for opioid use disorder
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Phenoxybenzamine
Atrium Therapeutics
Pheochromocytoma
1 trial -
Phenylephrine
United Therapeutics Europe Ltd
Spinal Anesthesia
1 trial -
Pioglitazone
Takeda
Nonalcoholic Steatohepatitis
1 trial -
Pioglitazone 15mg
United Therapeutics Europe Ltd
High Altitude
1 trial -
Pioglitazone then Placebo
Takeda
Diabetes
1 trial -
Placebo for Rimegepant 75 mg, VYDURA 75 mg oral lyophilisate
Pfizer Australia Pty Ltd
migraine headaches with or without aura
1 trial -
Placebo of rosuvastatin 10mg (tablet) as produced by Apotheek A15, Rosuvastatin tablet 10mg Apotheek A15
Disc Medicine
Statin-intolerance, High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)
1 trial -
Placebo suspension is identical to Symbioflor®2 liquid formulation in appearance, weight and composition, with the exception that the active ingredient will be omitted. Placebo constitutes are sodium chloride, magnesium sulphate 7H2O, potassium chloride, calcium chloride 2H2O, magnesium chloride 6H2O, and purified water, Symbioflor 2 Tropfen zum Einnehmen, Suspension
Alphapharm Pty Ltd
Irritable Bowel Syndrome
1 trial -
Placebo used in this trial is a foodgrade, redried potato starch. It is a white powder with bland taste and free from objectionable odours. Insoluble in water with a temperature below 50 °C and most organic solvents, solution is slightly hazy. The product is intended for use in food., POTATO STARCH, SODIUM CHLORIDE, AMILORIDE
Disc Medicine
Autosomal Dominant Polycystic Kidney Disease
1 trial -
Placebo, Desloratadine 5 mg orodispersible tablets, Bactil Flas 10 mg Liofilizados orales, Bilaxten 20 mg comprimidos bucodispersables
A. Menarini Industrie Farmaceutiche Riunite s.r.l.
Allergy
1 trial -
Plasma rich in growth factors
Wuhan Createrna Science and Technology Co., Ltd
Foot ulcers in diabetic patients with peripheral arterial disease
1 trial -
Plasma rich in growth factors, -
The George Institute
Glaucoma, Dry eye disease
1 trial -
Plasma rich in growth factors, Artific 3,20 mg/ml colirio en solución, Hidrathea 9 mg/ml colirio en solución
Wuhan Createrna Science and Technology Co., Ltd
Dry Eye Disease
1 trial -
Plavix 75 mg film-coated tablets, CARDIOASPIRIN 100 mg Compresse gastroresistenti, CARDIOASPIRIN 100 mg Compresse gastroresistenti, Plavix 300 mg film-coated tablets
Fondazione Telethon ETS
Patients with atrial fibrillation undergoing percutaneous left atrial appendage closure with the Amulet device
1 trial -
Praluent
Regeneron UK Limited
Heterozygous Familial Hypercholesterolemia
1 trial -
Pramipexole
The First People's Hospital of Lianyungang
Restless Legs Syndrome
1 trial -
Prednisolone
United Therapeutics Europe Ltd
COPD Exacerbation
1 trial -
Prednisona Pensa 5 mg comprimidos EFG, Simulect 20 mg powder for solution for injection or infusion, tacrolimus cinfa 1 mg cápsulas duras EFG, Micofenolato Mofetile Accord 250 mg capsule rigide, Metilprednisolona NORMON 40 mg polvo y disolvente para solución inyectable EFG, TIMOGLOBULINA 5 mg/ml, polvo para solución para perfusión
The George Institute
Kidney Transplant
1 trial -
Prednisone Mylan Pharma 5 mg compresse, Prednisone Mylan Pharma 5 mg compresse
Sana Biotechnology
Systemic Lupus Erythematosus
1 trial -
Pregabalin
Vera Therapeutics
Pain, Postoperative
1 trial -
Pregabalin
Yung NA
Diabetic Peripheral Neuropathy
1 trial -
Prevenar 13
United Therapeutics Europe Ltd
Sepsis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources